Concepedia

Mark Atwood

MA

Statistics

Publications

19

Citations

892

H-Index

15

Active since

2012

Affiliations

Policy Analysis (United States)(Current)

Pfizer (United States)

Roche (Switzerland)

Bristol-Myers Squibb (United States)

Pfizer (Germany)

Mark Atwood is an author at Policy Analysis (United States) specializing in medicine, infection control, and public health.

Top concepts

Publications per year

2012–2024

19

Publications

19

Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis

Michael Kreuter, Joyce Lee, Argyrios Tzouvelekis et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 188 citations · Full text

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

Marie‐Josée J. Mangen, Mark H. Rozenbaum, Susanne M. Huijts et al. · European Respiratory Journal · 2015 · 135 citations · Full text

Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Vincent Cottin, David M. Hansell, Nicola Sverzellati et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 106 citations

Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years

Derek Weycker, Reiko Sato, David Strutton et al. · Vaccine · 2012 · 57 citations

, , +12

Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures

Derek Weycker, John Edelsberg, Rich Barron et al. · Osteoporosis International · 2017 · 48 citations · Full text

1–5 of 19